Main sector:
Biotechnology - Therapeutics and Diagnostics
Subsectors:
Antibodies
Antibody-drug-conjugate
Indication:
Endocrine, nutritional and metabolic diseases / endocrinology
Products
In development: 7
Description:
Guangzhou Innogen Pharmaceutical Group Co., Ltd. is a Chinese biopharmaceutical company founded in 2014, focusing on the research and development of treatments for metabolic disorders such as diabetes and obesity.
